Imperial College Academic Health Science Centre is a partnership between Imperial College London, Imperial College Healthcare NHS Trust, the Royal Brompton & Harefield NHS Foundation Trust and The Royal Marsden NHS Foundation Trust.
Imperial College London
Imperial College London is a science-based university with an international reputation for excellence in teaching and research.
Consistently rated amongst the world’s best universities, Imperial is committed to developing the next generation of researchers, scientists and academics through collaboration across disciplines.
Located in the heart of London, Imperial is a multidisciplinary space for education, research, translation and commercialisation, harnessing science and innovation to tackle global challenges.
The AHSC encompasses the Imperial College Faculties – in Medicine, Natural Sciences, Engineering and the Business School.
The Faculty of Medicine is one of Europe’s largest medical schools, with 470 academic staff and equivalent numbers holding honorary contracts), and 1,300 undergraduate and postgraduate students (2011/12). Ranked third in Europe and fourth in the world for clinical, pre-clinical and health (Times Higher Education World University Rankings 2014-15).
Among the Faculty’s staff are ten Fellows of the Royal Society 2013, 76 Fellows of the Academy of Medical Sciences, 20 National Institute Health Research (NIHR) Senior Investigators and 16 Wellcome Trust Investigators
Imperial College Healthcare NHS Trust
Imperial College Healthcare NHS Trust was formed on October 1, 2007 by merging St Mary’s NHS Trust and Hammersmith Hospitals NHS Trust. With more than one million patient contacts each year, it is one of the largest acute Trusts in the country.
Royal Brompton & Harefield NHS Foundation Trust
The Royal Brompton & Harefield NHS Foundation Trust is a national and international specialist heart and lung centre based in Chelsea, London and Harefiled, Middlesex.
The Trust helps patients from all age groups who have heart and lung problems and is the country’s largest centre for the treatement of adult congenital heart disease.
The Royal Marsden NHS Foundation Trust
The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education.
Today, together with its academic partner, The Institute of Cancer Research (ICR), it is the largest and most comprehensive cancer centre in Europe treating over 50,000 NHS and private patients every year. It is a centre of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies.
The Royal Marsden, with the ICR, is the only National Institute for Health Research Biomedical Research Centre for Cancer, supporting pioneering research work carried out over a number of different cancer themes.